ESMO 2026

LONDON, United Kingdom, July 20, 2026 GSK plc has announced that the European Medicines Agency (EMA) has accepted its...

TEL AVIV, Israel & OSLO, Norway, July 20, 2026 BioLineRx Ltd. and Hemispherian AS have announced that new preclinical...

BARCELONA, Spain, July 17, 2026 Almirall S.A. has announced that the European Medicines Agency (EMA) has accepted the Marketing...

CAMBRIDGE, Mass., July 20, 2026 Marengo Therapeutics has announced that updated Phase II clinical data from its investigational immunotherapy...

SOUTH SAN FRANCISCO, Calif., July 17, 2026 IDEAYA Biosciences, Inc. has announced that it will present three clinical abstracts...

BOSTON, July 17, 2026 Compass Therapeutics, Inc. announced that Phase 2/3 clinical data from its investigational DLL4 × VEGF-A...

LEXINGTON, Mass., July 17, 2026 Agenus Inc. announced that three investigator-sponsored studies evaluating its investigational botensilimab plus balstilimab (BOT+BAL)...

PASADENA, Calif., July 17, 2026 Xencor, Inc. announced that Phase 1 clinical results for XmAb819, its investigational ENPP3 ×...

WILMINGTON, Del., July 17, 2026 Incyte has announced that it will present six oncology studies, including four rapid oral...

San Diego, California, USA | July 17, 2026 Zentalis Pharmaceuticals announced that it will present new clinical data for...